Cargando…

Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

Detalles Bibliográficos
Autores principales:	Crutel, Véronique, Lambert, Estelle, Penelaud, Pierre-François, Albarrán Severo, Cristina, Fuentes, Joaquin, Rosier, Antoine, Hervás, Amaia, Marret, Stéphane, Oliveira, Guiomar, Parellada, Mara, Kyaga, Simon, Gouttefangeas, Sylvie, Bertrand, Marianne, Ravel, Denis, Falissard, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496673/ https://www.ncbi.nlm.nih.gov/pubmed/33423216 http://dx.doi.org/10.1007/s10803-020-04822-8

Ejemplares similares

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
por: Crutel, Véronique, et al.
Publicado: (2020)

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

A randomised controlled trial of bumetanide in the treatment of autism in children
por: Lemonnier, E, et al.
Publicado: (2012)

Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018)

Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat
por: Wilkinson, Cassandra M., et al.
Publicado: (2019)

Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior
por: Goubert, Emmanuelle, et al.
Publicado: (2019)

Albumin human/bumetanide: Osmotic demyelination syndrome: case report
Publicado: (2020)

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
por: Boyarko, Ben, et al.
Publicado: (2023)

ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment
por: Fuentes, Joaquin, et al.
Publicado: (2020)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex
por: Vlaskamp, Chantal, et al.
Publicado: (2017)

Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy
por: Gharaylou, Zeinab, et al.
Publicado: (2019)

Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy
por: Guzel, Sibel, et al.
Publicado: (2020)

Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury
por: Nasirinezhad, Farinaz, et al.
Publicado: (2021)

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
por: Delpire, Eric, et al.
Publicado: (2022)

Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

Effect of Co-administration of Bumetanide and Phenobarbital on Seizure Attacks in Temporal Lobe Epilepsy
por: Rahmanzadeh, Reza, et al.
Publicado: (2018)

The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero
por: Skorput, Alexander GJ, et al.
Publicado: (2019)

Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol
por: Geertjens, Lisa, et al.
Publicado: (2022)

Bumetanide induces post-traumatic microglia–interneuron contact to promote neurogenesis and recovery
por: Tessier, Marine, et al.
Publicado: (2023)

Correction: Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

The extracellular space and epileptic activity in the adult brain: Explaining the antiepileptic effects of furosemide and bumetanide
por: Hochman, Daryl W
Publicado: (2012)

Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress
por: Hu, Die, et al.
Publicado: (2017)

Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study
por: Mollajani, Raheleh, et al.
Publicado: (2019)

The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis
por: Ben-Ari, Yehezkel, et al.
Publicado: (2022)

Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide
por: Zhao, Yongxiang, et al.
Publicado: (2022)

Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder
por: Lv, Hui, et al.
Publicado: (2022)

Mutagenic Mapping of the Na-K-Cl Cotransporter for Domains Involved in Ion Transport and Bumetanide Binding
por: Isenring, Paul, et al.
Publicado: (1998)

Characteristics of Acute Gout Flare in Patients Initiated on Intravenous Bumetanide for Acute Heart Failure Exacerbation
por: Jeong, Stephanie, et al.
Publicado: (2020)

Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
por: van Andel, Dorinde M., et al.
Publicado: (2020)

Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Wang, Tiantian, et al.
Publicado: (2021)

Don’t Get BUM’d Out: Bumetanide May yet Prove Beneficial for Neonatal Seizures
por: Stafstrom, Carl E.
Publicado: (2021)

The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder
por: Li, Qingyang, et al.
Publicado: (2022)

Long-term administration of bumetanide improve functional recovery after spinal cord injury in rats
por: Hashemizadeh, Shiva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_25oadjkuadgur7eor7sj88u5vj